RU2013129262A - Соединения и способы для восстановления кожи - Google Patents
Соединения и способы для восстановления кожи Download PDFInfo
- Publication number
- RU2013129262A RU2013129262A RU2013129262/15A RU2013129262A RU2013129262A RU 2013129262 A RU2013129262 A RU 2013129262A RU 2013129262/15 A RU2013129262/15 A RU 2013129262/15A RU 2013129262 A RU2013129262 A RU 2013129262A RU 2013129262 A RU2013129262 A RU 2013129262A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- alkyl
- skin defect
- scar
- alkenyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 9
- 230000007547 defect Effects 0.000 claims abstract 12
- 230000037303 wrinkles Effects 0.000 claims abstract 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract 9
- 231100000241 scar Toxicity 0.000 claims abstract 9
- 229910052799 carbon Inorganic materials 0.000 claims abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 8
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 8
- 229910052717 sulfur Inorganic materials 0.000 claims abstract 7
- 206010052428 Wound Diseases 0.000 claims abstract 6
- 208000027418 Wounds and injury Diseases 0.000 claims abstract 5
- 230000015572 biosynthetic process Effects 0.000 claims abstract 5
- 150000001412 amines Chemical class 0.000 claims abstract 4
- 229910052736 halogen Inorganic materials 0.000 claims abstract 4
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 125000003342 alkenyl group Chemical group 0.000 claims abstract 3
- 206010040925 Skin striae Diseases 0.000 claims abstract 2
- 208000031439 Striae Distensae Diseases 0.000 claims abstract 2
- 208000002847 Surgical Wound Diseases 0.000 claims abstract 2
- 230000001969 hypertrophic effect Effects 0.000 claims abstract 2
- 206010040954 Skin wrinkling Diseases 0.000 claims 9
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 6
- 239000000556 agonist Substances 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 208000009043 Chemical Burns Diseases 0.000 claims 1
- 208000018380 Chemical injury Diseases 0.000 claims 1
- 206010053615 Thermal burn Diseases 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000000732 arylene group Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000002993 cycloalkylene group Chemical group 0.000 claims 1
- 210000004709 eyebrow Anatomy 0.000 claims 1
- 210000001061 forehead Anatomy 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000005549 heteroarylene group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 230000036573 scar formation Effects 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- IKSUABKMJZDCNQ-UHFFFAOYSA-M Cc(ccc(OCc1cc(Cl)ccc1)c1)c1C(Nc1ccc(CC([O-])=O)cc1C)=O Chemical compound Cc(ccc(OCc1cc(Cl)ccc1)c1)c1C(Nc1ccc(CC([O-])=O)cc1C)=O IKSUABKMJZDCNQ-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41911510P | 2010-12-02 | 2010-12-02 | |
| US61/419,115 | 2010-12-02 | ||
| PCT/US2011/062691 WO2012075174A2 (en) | 2010-12-02 | 2011-11-30 | Compounds and methods for skin repair |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013129262A true RU2013129262A (ru) | 2015-01-10 |
Family
ID=45316123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013129262/15A RU2013129262A (ru) | 2010-12-02 | 2011-11-30 | Соединения и способы для восстановления кожи |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20120142684A1 (https=) |
| EP (2) | EP3195863A1 (https=) |
| JP (1) | JP2013544842A (https=) |
| KR (1) | KR20130119958A (https=) |
| CN (1) | CN103282033A (https=) |
| AR (1) | AR084144A1 (https=) |
| AU (1) | AU2011336582A1 (https=) |
| BR (1) | BR112013015781A2 (https=) |
| CA (1) | CA2819471A1 (https=) |
| CL (1) | CL2013001579A1 (https=) |
| MX (1) | MX2013006163A (https=) |
| RU (1) | RU2013129262A (https=) |
| SG (1) | SG190947A1 (https=) |
| TW (1) | TW201307313A (https=) |
| WO (1) | WO2012075174A2 (https=) |
| ZA (1) | ZA201303949B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103167875A (zh) * | 2010-08-17 | 2013-06-19 | 阿勒根公司 | 用于治疗角膜浑浊的ep2或ep4激动剂 |
| US8883139B2 (en) * | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) * | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8926963B2 (en) * | 2010-08-19 | 2015-01-06 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8900571B2 (en) * | 2010-08-19 | 2014-12-02 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8894992B2 (en) * | 2010-08-19 | 2014-11-25 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8889123B2 (en) * | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US20140142092A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Compounds and methods for skin repair |
| CA2890034A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations |
| US9546162B2 (en) * | 2013-09-27 | 2017-01-17 | Allergan, Inc. | Compounds and methods for skin repair |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
| TWI249520B (en) * | 1998-07-15 | 2006-02-21 | Ono Pharmaceutical Co | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient |
| KR20010074981A (ko) * | 1998-09-14 | 2001-08-09 | 우에노 도시오 | ω치환된 페닐프로스타그란딘 Ｅ 유도체 및 그 유도체를유효 성분으로 하는 약제 |
| CN100371322C (zh) * | 2001-07-16 | 2008-02-27 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素类化合物激动剂的2-吡咯烷酮衍生物 |
| EP2255829A3 (en) * | 2001-07-23 | 2012-03-28 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient |
| US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| ES2584606T3 (es) * | 2002-10-10 | 2016-09-28 | Ono Pharmaceutical Co., Ltd. | Microesferas que comprenden ONO-1301 |
| CA2511255C (en) * | 2003-01-10 | 2009-04-07 | F. Hoffmann-La Roche Ag | 2-piperidone derivatives as prostaglandin agonists |
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| US6875787B2 (en) | 2003-02-11 | 2005-04-05 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| WO2005027931A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist |
| WO2006137472A1 (ja) * | 2005-06-24 | 2006-12-28 | Taisho Pharmaceutical Co., Ltd. | プロスタグランジン誘導体 |
| US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
| US7439372B2 (en) * | 2006-05-03 | 2008-10-21 | Allergan, Inc. | Therapeutic compounds |
| US20080167377A1 (en) * | 2006-12-15 | 2008-07-10 | Alessandra Gaiba | Novel compounds |
| EP2120962A1 (en) * | 2006-12-18 | 2009-11-25 | Allergan, Inc. | Methods and compositions for treating gastrointestinal disorders |
| WO2008092862A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| WO2008092861A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| WO2008092860A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| GB0810615D0 (en) * | 2008-06-10 | 2008-07-16 | Glaxo Group Ltd | Novel pharmaceutical |
| US20110111031A1 (en) * | 2009-04-20 | 2011-05-12 | Guang-Liang Jiang | Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
| KR20130130694A (ko) * | 2010-07-30 | 2013-12-02 | 알러간, 인코포레이티드 | 피부 재생을 위한 화합물과 방법 |
| US8697056B2 (en) * | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
-
2011
- 2011-11-29 US US13/306,637 patent/US20120142684A1/en not_active Abandoned
- 2011-11-30 EP EP16198852.2A patent/EP3195863A1/en not_active Withdrawn
- 2011-11-30 AU AU2011336582A patent/AU2011336582A1/en not_active Abandoned
- 2011-11-30 EP EP11794357.1A patent/EP2646017B1/en not_active Not-in-force
- 2011-11-30 KR KR1020137017027A patent/KR20130119958A/ko not_active Withdrawn
- 2011-11-30 BR BR112013015781A patent/BR112013015781A2/pt not_active Application Discontinuation
- 2011-11-30 WO PCT/US2011/062691 patent/WO2012075174A2/en not_active Ceased
- 2011-11-30 JP JP2013542143A patent/JP2013544842A/ja active Pending
- 2011-11-30 RU RU2013129262/15A patent/RU2013129262A/ru not_active Application Discontinuation
- 2011-11-30 CA CA2819471A patent/CA2819471A1/en not_active Abandoned
- 2011-11-30 CN CN2011800627436A patent/CN103282033A/zh active Pending
- 2011-11-30 SG SG2013042171A patent/SG190947A1/en unknown
- 2011-11-30 MX MX2013006163A patent/MX2013006163A/es unknown
- 2011-12-02 TW TW100144475A patent/TW201307313A/zh unknown
- 2011-12-02 AR ARP110104524A patent/AR084144A1/es unknown
-
2013
- 2013-05-30 ZA ZA2013/03949A patent/ZA201303949B/en unknown
- 2013-05-31 CL CL2013001579A patent/CL2013001579A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011336582A1 (en) | 2013-07-11 |
| EP2646017A2 (en) | 2013-10-09 |
| SG190947A1 (en) | 2013-07-31 |
| AR084144A1 (es) | 2013-04-24 |
| EP3195863A1 (en) | 2017-07-26 |
| TW201307313A (zh) | 2013-02-16 |
| CL2013001579A1 (es) | 2013-12-27 |
| WO2012075174A3 (en) | 2012-07-26 |
| JP2013544842A (ja) | 2013-12-19 |
| BR112013015781A2 (pt) | 2018-11-06 |
| WO2012075174A2 (en) | 2012-06-07 |
| MX2013006163A (es) | 2013-10-30 |
| ZA201303949B (en) | 2014-08-27 |
| CA2819471A1 (en) | 2012-06-07 |
| EP2646017B1 (en) | 2016-11-16 |
| CN103282033A (zh) | 2013-09-04 |
| US20120142684A1 (en) | 2012-06-07 |
| KR20130119958A (ko) | 2013-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013129262A (ru) | Соединения и способы для восстановления кожи | |
| RU2013108394A (ru) | Соединения и способы восстановления кожи | |
| JP2013536183A5 (https=) | ||
| JP2013544842A5 (https=) | ||
| JP6543625B2 (ja) | ヒアルロン酸およびメピバカインを含む組成物 | |
| AU2018267578B2 (en) | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance | |
| RU2014113663A (ru) | Композиции кожного наполнителя для лечения мелких морщин | |
| KR20120027423A (ko) | 주입으로 인한 피부 반응 감소를 위한 필러와 아드레날린 수용체 작용제의 주사가능한 조합 | |
| EA021963B1 (ru) | Инъецируемая дерматологическая композиция для лечения морщин | |
| BR112013017875B1 (pt) | Composição oftálmica | |
| RU2011146005A (ru) | Композиции для лечения воспаления и способы лечения воспаления | |
| RU2013125042A (ru) | Способ предотвращения или лечения опухоли кожи | |
| AU2018201200B2 (en) | Method of treatment of eyelid laxity | |
| EA201591233A1 (ru) | Состав-депо для инъекций, включающий оптически активный толваптан, и способ его получения | |
| RU2005135428A (ru) | Поглощение макромолекул | |
| KR20190038840A (ko) | 피부 및/또는 모발 복구를 위한 5-하이드록시트립타민 1b 수용체-자극제 | |
| EA201270784A1 (ru) | Монотерапевтические композиции селективного липофильного и бета-агониста длительного действия и способы косметического лечения ожирения и контурного выпячивания | |
| JP2015537028A5 (https=) | ||
| KR20210153085A (ko) | 적어도 아미트리프탈린을 포함하는 수성 겔 형태의 국소 약제학적 조성물 | |
| US20170143733A1 (en) | Compounds and methods for skin repair | |
| RU2016110925A (ru) | Простагландин f2 альфа и его аналоги для лечения атрофического кожного рубцевания | |
| RU2010135795A (ru) | Замещенные цикорпентаны, обладающие простагландиновой активностью | |
| MATsUo et al. | The uptake of noradrenaline by the isolated rabbit's atrium treated with reserpine | |
| PE20060747A1 (es) | Composiciones farmaceuticas que contienen derivados de dolastatina-10 | |
| FR3058064A1 (fr) | Composition a base d'acide hyaluronique comprenant de la mepivacaine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20160913 |